INTERNATIONAL ISOTOPES INC.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549


FORM 8-K


CURRENT REPORT

Pursuant To Section 13 or 15(d) of the

 Securities Exchange Act of 1934


Date of report (Date of earliest event reported): November 2, 2010



INTERNATIONAL ISOTOPES INC.

(Exact Name of Registrant as Specified in Its Charter)


TEXAS

0-22923

74-2763837  

(State or Other Jurisdiction of Incorporation)

(Commission File Number)

(IRS Employer Identification No.)


4137 Commerce Circle

Idaho Falls, Idaho

 

83401

(Address of Principal Executive Offices)

 

(Zip Code)


208-524-5300

(Registrant’s Telephone Number, Including Area Code)


N/A

(Former Name or Former Address, if Changed Since Last Report)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))




Item 7.01

Regulation FD Disclosure.


In connection with the financing described in the Current Report on Form 8-K filed by the Company on November 1, 2010, the Company made presentations to potential investors using materials that contained information regarding the Company and its proposed de-conversion and Fluoride Extraction Process business.  The Company has elected to furnish the materials presented to the potential investors as Exhibit 99.1 to this Current Report on Form 8-K.



Item 9.01

Financial Statements and Exhibits


(d) Exhibits


99.1

Investor Presentation.







SIGNATURES


 


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


 

International Isotopes, Inc.

 

 

 

 

 

 

 

 

 

 

 

 

 Date: November 2, 2010

By:

/s/ Steve T. Laflin

 

 

Steve T. Laflin

 

 

President and Chief Executive Officer



 

 

 

EXHIBIT INDEX

 

 

 

Exhibit

 

 

Number

 

Description of Document

 

 

 

99.1

 

Investor Presentation.